XML 113 R115.htm IDEA: XBRL DOCUMENT v2.4.1.9
Subsequent Events (Details) (USD $)
Share data in Millions, except Per Share data, unless otherwise specified
0 Months Ended
Feb. 24, 2015
Jan. 27, 2015
Jan. 29, 2015
Feb. 10, 2015
Dec. 31, 2014
Subsequent Event | AMS          
Subsequent Event [Line Items]          
Disposal Group, Expected Sale Price $ 1,650,000,000endp_DisposalGroupExpectedSalePrice
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= endp_AmsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
       
Expected Proceeds from Divestiture of Businesses 1,600,000,000endp_ExpectedProceedsfromDivestitureofBusinesses
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= endp_AmsMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
       
Subsequent Event | Maximum | AMS          
Subsequent Event [Line Items]          
Disposal Group, Expected Milestone Payment 50,000,000endp_DisposalGroupExpectedMilestonePayment
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= endp_AmsMember
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
       
Subsequent Event | 6.00% Senior Notes Due 2025          
Subsequent Event [Line Items]          
Face value of debt instrument   1,200,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Interest Rate (percent)   6.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Debt Instrument, Redemption Price, Percentage   101.00%us-gaap_DebtInstrumentRedemptionPricePercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | From February 1, 2020 to and including January 31, 2021          
Subsequent Event [Line Items]          
Redemption Percentage   103.00%endp_RedemptionPercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_FromFebruary12020toandincludingJanuary312021Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | From February 1, 2021 to and including January 31, 2022          
Subsequent Event [Line Items]          
Redemption Percentage   102.00%endp_RedemptionPercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_FromFebruary12021toandincludingJanuary312022Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | From February 1, 2022 to and including January 31, 2023          
Subsequent Event [Line Items]          
Redemption Percentage   101.00%endp_RedemptionPercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_FromFebruary12022toandincludingJanuary312023Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | From February 1, 2023 and thereafter          
Subsequent Event [Line Items]          
Redemption Percentage   100.00%endp_RedemptionPercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_FromFebruary12023andthereafterMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | Prior To February 1, 2018          
Subsequent Event [Line Items]          
Debt Instrument, Redemption Price, Percentage   106.00%us-gaap_DebtInstrumentRedemptionPricePercentage
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_PriorToFebruary12018Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Subsequent Event | 6.00% Senior Notes Due 2025 | Prior To February 1, 2018 | Maximum          
Subsequent Event [Line Items]          
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed   35.00%us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
/ us-gaap_DebtInstrumentAxis
= endp_A6.00SeniorNotesDue2025Member
/ us-gaap_DebtInstrumentRedemptionPeriodAxis
= endp_PriorToFebruary12018Member
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
     
Auxilium Pharmaceuticals, Inc. | Subsequent Event          
Subsequent Event [Line Items]          
Total acquisition consideration     3,000,000,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Payments to acquire business     790,800,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Shares, Outstanding     54.97us-gaap_SharesOutstanding
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business Combination, Termination Fee     28,400,000endp_BusinessCombinationTerminationFee
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Auxilium Pharmaceuticals, Inc. | Subsequent Event | 1.50% Convertible Senior Notes Due 2018          
Subsequent Event [Line Items]          
Face value of debt instrument     350,000,000us-gaap_DebtInstrumentFaceAmount
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_DebtInstrumentAxis
= endp_A1.50ConvertibleSeniorNotesDue2018Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Interest Rate (percent)     1.50%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_DebtInstrumentAxis
= endp_A1.50ConvertibleSeniorNotesDue2018Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Convertible notes, convertible amount per share (in dollars per share)     $ 9.88us-gaap_DebtInstrumentConvertibleConversionPrice1
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_DebtInstrumentAxis
= endp_A1.50ConvertibleSeniorNotesDue2018Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Debt Instrument, Convertible, Conversion Ratio     0.3430us-gaap_DebtInstrumentConvertibleConversionRatio1
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.Member
/ us-gaap_DebtInstrumentAxis
= endp_A1.50ConvertibleSeniorNotesDue2018Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Auxilium Pharmaceuticals, Inc., Consideration Option One | Subsequent Event          
Subsequent Event [Line Items]          
Percentage Of Common Shares Outstanding     94.90%endp_PercentageOfCommonSharesOutstanding
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionOneMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business combination, consideration, equity, ratio     0.488endp_BusinessCombinationConsiderationEquityRatio
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionOneMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Auxilium Pharmaceuticals, Inc., Consideration Option One, Prorated For Oversubscription [Member] | Subsequent Event          
Subsequent Event [Line Items]          
Business combination, consideration, equity, ratio     0.3448endp_BusinessCombinationConsiderationEquityRatio
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionOneProratedForOversubscriptionMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business acquisition, share price (in dollars per share)     $ 9.75us-gaap_BusinessAcquisitionSharePrice
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionOneProratedForOversubscriptionMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Auxilium Pharmaceuticals, Inc., Consideration Option Two | Subsequent Event          
Subsequent Event [Line Items]          
Percentage Of Common Shares Outstanding     0.40%endp_PercentageOfCommonSharesOutstanding
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionTwoMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business combination, consideration, cash, percent     100.00%endp_BusinessCombinationConsiderationCashPercent
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionTwoMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business acquisition, share price (in dollars per share)     $ 33.25us-gaap_BusinessAcquisitionSharePrice
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionTwoMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Auxilium Pharmaceuticals, Inc., Consideration Option Three | Subsequent Event          
Subsequent Event [Line Items]          
Percentage Of Common Shares Outstanding     4.70%endp_PercentageOfCommonSharesOutstanding
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionThreeMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business combination, consideration, equity, ratio     0.244endp_BusinessCombinationConsiderationEquityRatio
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionThreeMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Business acquisition, share price (in dollars per share)     $ 16.625us-gaap_BusinessAcquisitionSharePrice
/ us-gaap_BusinessAcquisitionAxis
= endp_AuxiliumPharmaceuticalsInc.ConsiderationOptionThreeMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
   
Litha Healthcare Group Limited | Paladin Labs Inc.          
Subsequent Event [Line Items]          
Percentage of equity method of investments in subsidiaries         70.30%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_BusinessAcquisitionAxis
= endp_LithaHealthcareGroupLimitedMember
/ dei_LegalEntityAxis
= endp_PaladinLabsInc.Member
Escrow deposit         40,200,000us-gaap_EscrowDeposit
/ us-gaap_BusinessAcquisitionAxis
= endp_LithaHealthcareGroupLimitedMember
/ dei_LegalEntityAxis
= endp_PaladinLabsInc.Member
Litha Healthcare Group Limited | Subsequent Event | Paladin Labs Inc.          
Subsequent Event [Line Items]          
Total acquisition consideration       $ 40,100,000us-gaap_BusinessCombinationConsiderationTransferred1
/ us-gaap_BusinessAcquisitionAxis
= endp_LithaHealthcareGroupLimitedMember
/ dei_LegalEntityAxis
= endp_PaladinLabsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
 
Business acquisition, share price (in dollars per share)       $ 0.24us-gaap_BusinessAcquisitionSharePrice
/ us-gaap_BusinessAcquisitionAxis
= endp_LithaHealthcareGroupLimitedMember
/ dei_LegalEntityAxis
= endp_PaladinLabsInc.Member
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember